Lataa...
Evaluation of plasma microRNA levels to predict insensitivity of patients with advanced lung adenocarcinomas to pemetrexed and platinum
Pemetrexed combined with platinum is a first-line therapy used to treat patients with advanced non-small cell lung cancer (NSCLC) that exhibit negative or unknown epidermal growth factor receptor (EGFR) mutational status or anaplastic lymphoma kinase (ALK) rearrangements. Lung adenocarcinoma (LAC) i...
Tallennettuna:
Julkaisussa: | Oncol Lett |
---|---|
Päätekijät: | , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
D.A. Spandidos
2016
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5228282/ https://ncbi.nlm.nih.gov/pubmed/28101226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.5295 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|